M. D. Saiful A. Siddiqui

Array ( [id] => 3622381 [patent_doc_number] => 05593983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Substituted 2.beta.-morpholino-androstane derivatives' [patent_app_type] => 1 [patent_app_number] => 8/347974 [patent_app_country] => US [patent_app_date] => 1994-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14202 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593983.pdf [firstpage_image] =>[orig_patent_app_number] => 347974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3553940 [patent_doc_number] => 05519016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-21 [patent_title] => 'Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent' [patent_app_type] => 1 [patent_app_number] => 8/341295 [patent_app_country] => US [patent_app_date] => 1994-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18666 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 757 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/519/05519016.pdf [firstpage_image] =>[orig_patent_app_number] => 341295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3573824 [patent_doc_number] => 05539114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-23 [patent_title] => 'Process for the preparation of substituted quinazoline-2,4,-diones' [patent_app_type] => 1 [patent_app_number] => 8/339948 [patent_app_country] => US [patent_app_date] => 1994-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3289 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 193 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/539/05539114.pdf [firstpage_image] =>[orig_patent_app_number] => 339948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3490070 [patent_doc_number] => 05470857 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Carbocyclic nucleoside analogs useful as immunosuppressants' [patent_app_type] => 1 [patent_app_number] => 8/336706 [patent_app_country] => US [patent_app_date] => 1994-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8804 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470857.pdf [firstpage_image] =>[orig_patent_app_number] => 336706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589750 [patent_doc_number] => 05550239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Process for large-scale production of indolyl alkyl pyrimidinyl piperazine compounds' [patent_app_type] => 1 [patent_app_number] => 8/336022 [patent_app_country] => US [patent_app_date] => 1994-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7335 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550239.pdf [firstpage_image] =>[orig_patent_app_number] => 336022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3441859 [patent_doc_number] => 05430036 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-04 [patent_title] => '6,11-substituted-6,11-dihydrobenzo[b]quinolizinium salts and compositions and method of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/328941 [patent_app_country] => US [patent_app_date] => 1994-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9880 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/430/05430036.pdf [firstpage_image] =>[orig_patent_app_number] => 328941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723851 [patent_doc_number] => 05672600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Antimicrobial dithiocarbamoyl quinolones' [patent_app_type] => 1 [patent_app_number] => 8/327063 [patent_app_country] => US [patent_app_date] => 1994-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11320 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 553 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672600.pdf [firstpage_image] =>[orig_patent_app_number] => 327063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3418341 [patent_doc_number] => 05434159 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-07-18 [patent_title] => '6,11-cyclyl-1,2,3,4,5,6,11,11a-octahydrobenzo[b]quinolines and compositions and method of use thereof' [patent_app_type] => 1 [patent_app_number] => 8/320013 [patent_app_country] => US [patent_app_date] => 1994-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13543 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/434/05434159.pdf [firstpage_image] =>[orig_patent_app_number] => 320013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3608986 [patent_doc_number] => 05589476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Imidazol-4-ylpiperidine derivatives, their preparation and their application in therapeutics' [patent_app_type] => 1 [patent_app_number] => 8/317661 [patent_app_country] => US [patent_app_date] => 1994-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7049 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589476.pdf [firstpage_image] =>[orig_patent_app_number] => 317661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3429867 [patent_doc_number] => 05463047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-31 [patent_title] => 'Intermediates for the manufacture of 4-acyloxy-3-hydroxyethylazetidinones' [patent_app_type] => 1 [patent_app_number] => 8/306863 [patent_app_country] => US [patent_app_date] => 1994-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8773 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/463/05463047.pdf [firstpage_image] =>[orig_patent_app_number] => 306863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588629 [patent_doc_number] => 05516776 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-14 [patent_title] => 'Enantioselective synthesis of antifolates' [patent_app_type] => 1 [patent_app_number] => 8/304751 [patent_app_country] => US [patent_app_date] => 1994-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9133 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/516/05516776.pdf [firstpage_image] =>[orig_patent_app_number] => 304751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3472899 [patent_doc_number] => 05476851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 8/303097 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9963 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476851.pdf [firstpage_image] =>[orig_patent_app_number] => 303097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3701031 [patent_doc_number] => 05646121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Pseudopeptides with antiviral activity' [patent_app_type] => 1 [patent_app_number] => 8/302064 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12856 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646121.pdf [firstpage_image] =>[orig_patent_app_number] => 302064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682423 [patent_doc_number] => 05633231 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Valine-containing pseudopeptides with antiviral activity' [patent_app_type] => 1 [patent_app_number] => 8/301506 [patent_app_country] => US [patent_app_date] => 1994-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12834 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1332 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633231.pdf [firstpage_image] =>[orig_patent_app_number] => 301506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761403 [patent_doc_number] => 05741794 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Heterocyclic sulfonamide derivatives as antagonists of PAF and angiotensin II' [patent_app_type] => 1 [patent_app_number] => 8/256139 [patent_app_country] => US [patent_app_date] => 1994-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21356 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741794.pdf [firstpage_image] =>[orig_patent_app_number] => 256139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3649898 [patent_doc_number] => 05605896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Bicyclic heterocyclic derivatives having .alpha..sub.1 adrenergic and 5HT.sub.1A activities' [patent_app_type] => 1 [patent_app_number] => 8/299188 [patent_app_country] => US [patent_app_date] => 1994-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74330 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 496 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605896.pdf [firstpage_image] =>[orig_patent_app_number] => 299188 [rel_patent_id] =>[rel_patent_doc_number] =>)